concept

DOPAMINERGIC NEURONS

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about DOPAMINERGIC NEURONS: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

632Connections

2Hypotheses

0Analyses

50Outgoing

50Incoming

0Experiments

0Debates

No summary available yet.

View on Wiki →

No AI portrait yet

💡 Concept Info

Name	DOPAMINERGIC NEURONS
Key Genes/Proteins	ACTB, AIF1, AKT, Alpha-Synuclein, ALPHA-SYNUCLEIN, AMPK
Related Diseases	aging, AGING, ALZHEIMER'S DISEASE
Related Pathways	AMPK SIGNALING

Pathway Diagram

graph TD
    DOPAMINERGIC_NEURONS["DOPAMINERGIC NEURONS"]
    DOPAMINERGIC_NEURONS -->|"involved_in"| Parkinson_s_Disease["Parkinson's Disease"]
    DOPAMINERGIC_NEURONS -->|"expressed in"| SUBSTANTIA_NIGRA["SUBSTANTIA NIGRA"]
    DOPAMINERGIC_NEURONS -->|"activates"| NEURON["NEURON"]
    DOPAMINERGIC_NEURONS -->|"depletes"| PARKINSON_S_DISEASE["PARKINSON'S DISEASE"]
    DOPAMINERGIC_NEURONS -->|"activates"| MICROGLIA["MICROGLIA"]
    Parkinson_s_Disease -->|"causes"| DOPAMINERGIC_NEURONS
    ALPHA_SYNUCLEIN["ALPHA-SYNUCLEIN"] -->|"contributes to"| DOPAMINERGIC_NEURONS
    Emodin["Emodin"] -.protects against.-> DOPAMINERGIC_NEURONS
    PS_NPs["PS-NPs"] -->|"inhibits"| DOPAMINERGIC_NEURONS
    alpha_synuclein["alpha-synuclein"] -->|"causes"| DOPAMINERGIC_NEURONS
    Cellular_Senescence["Cellular Senescence"] -->|"expressed in"| DOPAMINERGIC_NEURONS
    Polystyrene_Nanoplastics["Polystyrene Nanoplastics"] -->|"targets"| DOPAMINERGIC_NEURONS

Outgoing (180)

Target	Relation	Type	Str
Parkinson'S Disease	involved_in	disease	0.95
Parkinson'S Disease	risk_factor_for	disease	0.95
NEURON	activates	cell_type	0.95
PARKINSON'S DISEASE	depletes	disease	0.95
Parkinson's Disease	involved_in	disease	0.95
NEURON	contributes_to	cell_type	0.95
MICROGLIA	activates	cell_type	0.95
SUBSTANTIA NIGRA	causes	brain_region	0.95
NEURODEGENERATION	activates	process	0.95
NEURON	interacts_with	cell_type	0.95
SUBSTANTIA NIGRA	associated_with	brain_region	0.95
SUBSTANTIA NIGRA	expressed_in	entity	0.95
Parkinson's Disease	biomarker_for	disease	0.92
Substantia Nigra Pars Compacta	expressed_in	cell_type	0.90
Neurodegeneration	involved_in	process	0.85
Aging	associated_with	phenotype	0.85
Motor Dysfunction	involved_in	phenotype	0.85
Neurodegeneration	risk_factor_for	process	0.80
Calcium Handling	involved_in	process	0.80
NEURODEGENERATION	causes	process	0.80
PARKINSON'S DISEASE	activates	disease	0.80
PARKINSON'S DISEASE	contributes_to	disease	0.80
NEURON	inhibits	cell_type	0.80
oxidative stress response	active_in	pathway	0.75
substantia nigra	expressed_in	brain_region	0.70
substantia nigra pars compacta	expressed_in	brain_region	0.70
mitophagy	expresses	process	0.70
Parkinson's Disease	associated_with	disease	0.70
neurodegeneration	activates	disease	0.70
LRRK2	interacts_with	gene	0.65
NEURON	depletes	cell_type	0.65
PARKINSON'S DISEASE	protects_against	disease	0.65
PARKINSON'S DISEASE	regulates	disease	0.65
NEURON	implicated_in	cell_type	0.65
NEURON	expressed_in	cell_type	0.65
INFLAMMATION	activates	process	0.65
NEURON	causes	cell_type	0.65
PARKINSON'S DISEASE	interacts_with	disease	0.65
STRIATUM	activates	brain_region	0.65
SUBSTANTIA NIGRA	activates	brain_region	0.65
VENTRAL TEGMENTAL AREA	activates	brain_region	0.65
STEM CELLS	activates	cell_type	0.65
NEURODEGENERATION	associated_with	process	0.65
pyroptosis	activates	process	0.60
neurodegeneration	regulates	disease	0.60
Parkinson's disease	regulates	disease	0.60
neuroinflammation	activates	disease	0.60
Parkinson's disease	activates	disease	0.60
ferroptosis	protects_against	process	0.60
epigenetic regulation	active_in	pathway	0.55

Incoming (452)

Source	Relation	Type	Str
USP30	protects_against	gene	1.00
lipid accumulation	drives	process	1.00
ALPHA-SYNUCLEIN	contributes_to	gene	0.95
CELLULAR SENESCENCE	associated_with	entity	0.95
Parkinson's Disease	causes	disease	0.95
Gentiopicroside	protects_against	compound	0.95
Lipid Accumulation	causes	process	0.95
Substantia Nigra Pars Compacta	expressed_in	brain_region	0.95
Parkinson's Disease	causes	disease	0.95
Substantia Nigra Pars Compacta	associated_with	cell_type	0.95
Parkinson's Disease	associated_with	disease	0.95
Alpha-Synuclein Aggregation	causes	process	0.92
Emodin	protects_against	drug	0.91
neurodegeneration	affects	disease	0.90
Parkinson's disease	affects	disease	0.90
Lipid Aggregation	involved_in	process	0.90
LNK	regulates	gene	0.90
PS-NPs	inhibits	drug	0.90
34251648	has neuroprotective roles in	paper	0.90
Lipid Accumulation	associated_with	process	0.90
Lipid Accumulation	expressed_in	process	0.90
Cellular Senescence	expressed_in	process	0.90
neuroinflammation	causes	process	0.90
neuroinflammation	affects	disease	0.90
Polystyrene Nanoplastics	targets	compound	0.90
Parkinson'S Disease	associated_with	disease	0.90
METTL3	expressed_in	gene	0.90
38501412	protects	paper	0.90
41460594	protects and inhibits ferroptosis in	paper	0.90
OTUD6A	upregulates	gene	0.90
Oxidative Stress	causes	process	0.90
Parkinson'S Disease	causes	disease	0.90
Polystyrene Nanoplastics	causes	compound	0.90
CRSJ	protects_against	drug	0.90
alpha-synuclein	causes	protein	0.90
DOPAMINE BIOSYNTHESIS	expressed_in	pathway	0.90
MPTP	causes	drug	0.88
Lipid Droplets	associated_with	process	0.85
GLUCOCEREBROSIDES	causes	process	0.85
PINK1	protects_against	gene	0.85
Ferroptosis	causes	process	0.85
Astrocytes	interacts_with	cell_type	0.85
B3GALT4	expressed_in	gene	0.85
Cytokines	causes	protein	0.85
Lipid Droplets	expressed_in	process	0.85
BHBA	protects_against	compound	0.85
Α-SYNUCLEIN	causes	protein	0.85
Gene Expression	biomarker_for	process	0.85
Atremorine	protects_against	drug	0.85
lipid droplet accumulation	contributes_to	process	0.85

Targeting Hypotheses (2)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
LAMP2A Liquid-Liquid Phase Separation Defects in Dopaminergi	0.783	neurodegeneration	-
GBA1 Loss Triggers a TFEB-to-TFE3 Compensatory Switch in A9	0.750	neurodegeneration	-

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Experiments (0)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

Debates (0)

Multi-agent debates referencing this entity

No debates reference this entity

Related Research

Hypotheses and analyses mentioning DOPAMINERGIC NEURONS in their description or question text

No additional research found